Sign in
Taking people in South KoreaNo phase

Intensive Versus Standard Care for Cholesterol in Hypertension and Diabetes

Tests intensive cholesterol care and education in adults with high blood pressure or diabetes.

Key facts

Who runs it
Saint Vincent's Hospital, Korea
Where
Gyeonggi-do, South KoreaSee the site
Trial code
Registry title
Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
Status
Recruiting
People taking part
348 people, planned
Started
1 Apr 2025
Planned end
30 Jun 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • centralized management and education group
Record updated
1 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 30 to 80 who are registered in the Hanam City Hypertension and Diabetes Program. It compares intensive and standard care and education for blood fat (lipid) problems.

Age
30 to 80 years
Sex
All sexes can join.
Disease stage
Registered in the Hanam City Hypertension and Diabetes Program.

Main reasons for not taking part

  • Chronic kidney disease stage 4 or higher (eGFR <30 mL/min/1.73m²)
  • Liver cirrhosis or severe liver disease
  • Acute coronary syndrome in the past 6 months
  • Pregnant or breastfeeding women
  • Psychiatric disorders that may affect taking part in the study

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients registered in the Hanam City Hypertension and Diabetes Program
  • Adults aged 30 to 80 years
  • Individuals who have provided written informed consent to participate in the study

Who cannot take part

  • Patients with liver cirrhosis or severe liver disease
  • Patients with a history of acute coronary syndrome within the past 6 months
  • Pregnant or breastfeeding women • Individuals with psychiatric disorders that may affect study participation
  • Chronic kidney disease stage 4 or higher (eGFR <30 mL/min/1.73m²)

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 80 years old?

Where in South Korea

  • Catholic University of Korea, ST. Vincent's Hospital.Gyeonggi-do, South KoreaContact: Sung-Ho HerTaking people

About the trial

What the trial wants to find out

The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications. Therefore, a more structured and intensive approach to management and education is required.

Read full original descriptionShow less

This study aims to implement intensive dyslipidemia management and education for patients registered at the Hanam City Hypertension and Diabetes Education Center and evaluate changes in blood lipid levels accordingly. Additionally, the study will analyze the impact of intensive education on patients' quality of life, health behaviors, and treatment adherence, ultimately contributing to the development of effective management strategies.

The 2 groups in the trial

  • Intensive Care and Education GroupTreatment being tested

    Through a visit to the center in 0 months, two instructors, one nurse and one nutritionist, provide an hour of diabetes and high blood pressure 1:15 group education, and an additional hour of lipid abnormalities and effects 1:15 group education. A total of two hours of education will be conducted, and the same content of lipid abnormality education conducted in 0 months will be conducted for an hour through visits in the third month. Hyperlipidemia education is conducted in the form of 1:15 small group education with the same content conducted in 0 months or 1:87 size group education. In particular, 1:87 form of large-scale education will be operated as a dialogue-oriented lecture that asks and answers questions, and will be conducted by doctors. In addition, in two months and four months, education on diabetes, high blood pressure, and dyslipidemia will be conducted briefly for three minutes through non-face-to-face management phone calls, not visits.

    Treatment: centralized management and education group

  • Standard Care and Education GroupNo study treatment, for comparison

    For only 0 months, two instructors, one nurse and one nutritionist, will provide 1 hour of diabetes and high blood pressure 1:15 group education, which corresponds to standard management education.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
Plain-language title
Intensive Versus Standard Care for Cholesterol in Hypertension and DiabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Criteria questions
Built from NCT07045623, who can take part
Record updated
1 July 2025